特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
922068

世界のqPCR試薬市場:成長、動向、および予測

qPCR Reagents Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
世界のqPCR試薬市場:成長、動向、および予測
出版日: 2020年06月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 111 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートは世界のqPCR試薬市場について調査しており、市場機会や動向、成長および阻害要因、検出方法・パッキングタイプ・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
    • 感染症および遺伝性疾患の発生率の上昇
    • 高齢者人口の増加
    • ヒトゲノム計画 の開始・完了
  • 市場阻害要因
    • PCRと比較した機器のコストの高さ
    • qPCR機器を操作するための技術的専門知識の欠如
  • ポーターのファイブフォース分析

第5章 市場セグメンテーション

  • 検出方法別
    • 色素ベース
    • プローブ・プライマーベース
  • パッキングタイプ別
    • qPCRコアキット
    • qPCR用マスターミックス
  • エンドユーザー別
    • 病院・診断センター
    • 研究所・学術機関
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffman-La Roche Ltd.
    • Promega Corporation
    • Qiagen NV
    • Quanta Biosciences, Inc.
    • Sigma-Aldrich Corporation (Merck KGaA)
    • タカラバイオ株式会社
    • Thermo Fisher Scientific

第7章 市場機会および今後の動向

目次
Product Code: 67598

A real-time polymerase chain reaction (real-time PCR) or quantitative polymerase chain reaction (qPCR), is a laboratory technique of molecular biology based on the polymerase chain reaction (PCR). It monitors the amplification of a targeted DNA molecule during the PCR.

Rising incidence of infectious diseases and genetic diseases have increased the demand for diagnostic tests that may help people take precautionary measures. Growing geriatric population has also increased the demand for fpr genetic tests. Many genome projects have been initiated in the past decade. This has allowed researchers to understand the human genome more. These projects require gene sequencing and genetic tests to understand the human gene sequence. These demand s have helped the growth of qPCR equipment, which has in turn boosted the growth of qPCR equipment market.

However, the high cost of qPCR equipment and lack of high technical expertise to operate qPCR equipment have been restraining the market growth.

Key Market Trends

Dye-Based qPCR Reagents are Expected to Dominate the Market

The use of fluorescent DNA-binding dyes is one of the most straightforward and common qPCR approaches used by scientists. A dye is added to the reaction, and fluorescence is measured at each PCR cycle. Because fluorescence of these dyes increases dramatically in the presence of double-stranded DNA, DNA synthesis can be monitored as an increase in fluorescent signal.

Dye-based diagnostic qualitative PCR is applied to rapidly detect nucleic acids that are diagnostic of, for example, infectious diseases, cancer and genetic abnormalities. Moreover, Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 2018 (17 million).

North America is Expected to Dominate the Market

Prevalence of cancer in United States is one of the highest in North American countries. According to a 2018 report by the National Cancer Institute, the incidence of cancer in the US is 439.2 per 100,000 men and women per year. Prevalence of infectious disease is also high in United States and Mexico. This has created high demand for qPCR diagnostic tests, which is increasing the demand for qPCR reagents as well.

However, the United States has a developed and well-structured health care system. The system also encourages research and development. These policies encourage global players to enter the US, and eventually the North American market. As a result, this region enjoys the presence of many global market players. As high demand is met by the presence of global players in the region, the market is further expected to increase.

Competitive Landscape

Majority of the qPCR reagents are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Infectious Diseases and Genetic Disorders
    • 4.2.2 Growing Geriatric Population
    • 4.2.3 Initiation and Completion of the Human Genome Projects
  • 4.3 Market Restraints
    • 4.3.1 Cost of the Instrument as Compared to PCR
    • 4.3.2 Lack of Technical Expertise to Operate the qPCR instrument
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Detection Method
    • 5.1.1 Dye-Based qPCR Reagents
    • 5.1.2 Probes and Primer-Based qPCR Reagents
  • 5.2 By Packaging Type
    • 5.2.1 qPCR Core Kits
    • 5.2.2 qPCR Mastermixes
  • 5.3 By End-User
    • 5.3.1 Hospitals & Diagnostic Centers
    • 5.3.2 Research Laboratories & Academic Institutes
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Affymetrix, Inc.
    • 6.1.2 Agilent Technologies, Inc.
    • 6.1.3 Bio-Rad Laboratories, Inc.
    • 6.1.4 F. Hoffman-La Roche Ltd.
    • 6.1.5 Promega Corporation
    • 6.1.6 Quanta Biosciences, Inc.
    • 6.1.7 Sigma-Aldrich Corporation (Merck KGaA)
    • 6.1.8 Takara Bio Inc.
    • 6.1.9 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.